Skip to main content

Table 3 Quality of life in insulin-naïve and insulin-experienced patients, and in the total cohort

From: Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational study

   Insulin-experienced, N = 1,966 Insulin-naïve, N = 6,612 Total cohort, N = 8,578
EQ-5D VAS (Scale 0-100) N 1390 4713 6103
Baseline 75.3 (14.1) 75.9 (13.4) 75.8 (13.6)
Week 24 82.0 (11.3) 82.0 (10.3) 82.0 (10.6)
Change 6.7 (15.8) 6.1 (14.4) 6.2 (14.7)
P value <0.001 <0.001 <0.001
QoL UK (Scale 0-1) N 1406 4814 6220
Baseline 0.851 (0.190) 0.882 (0.176) 0.875 (0.179)
Week 24 0.886 (0.170) 0.896 (0.157) 0.893 (0.160)
Change 0.035 (0.228) 0.014 (0.218) 0.018 (0.221)
P value <0.001 <0.001 <0.001
Mobility dimension N 1416 4843 6259
No problems with walking (%) Baseline 1197 (84.5) 4333 (89.5) 5530 (88.4)
Week 24 1289 (91.0) 4433 (91.5) 5722 (91.4)
P value <0.0001 0.0005 <0.0001
Self-care dimension N 1415 4845 6260
No problems with self-care (%) Baseline 1301 (91.9) 4475 (92.4) 5776 (92.3)
Week 24 1280 (90.5) 4483 (92.5) 5763 (92.1)
P value 0.1635 0.7584 0.6655
Usual activities dimension N 1415 4841 6256
No problems with performing usual activities (%) Baseline 1222 (86.4) 4316 (89.2) 5538 (88.5)
Week 24 1236 (87.3) 4272 (88.2) 5508 (88.0)
P value 0.4361 0.1578 0.4043
Pain/discomfort dimension N 1411 4832 6243
No pain or discomfort (%) Baseline 1007 (71.4) 3820 (79.1) 4827 (77.3)
Week 24 1138 (80.7) 4031 (83.4) 5169 (82.8)
P value <0.0001 <0.0001 <0.0001
Anxiety/depression dimension N 1413 4837 6250
Not anxious or depressed (%) Baseline 1014 (71.8) 3624 (74.9) 4638 (74.2)
Week 24 1067 (75.5) 3749 (77.5) 4816 (77.1)
P value 0.0236 0.0028 0.0002
  1. Data are mean (sd), n or percentage.